Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma

Clinical trial NCT00017316 · COMPLETED

Trial details

NCT number: NCT00017316
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2001-03-01
Primary completion: 2003-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.